» Articles » PMID: 10364117

Risk Factors for Erysipelas of the Leg (cellulitis): Case-control Study

Overview
Journal BMJ
Specialty General Medicine
Date 1999 Jun 11
PMID 10364117
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess risk factors for erysipelas of the leg (cellulitis).

Design: Case-control study.

Setting: 7 hospital centres in France.

Subjects: 167 patients admitted to hospital for erysipelas of the leg and 294 controls.

Results: In multivariate analysis, a disruption of the cutaneous barrier (leg ulcer, wound, fissurated toe-web intertrigo, pressure ulcer, or leg dermatosis) (odds ratio 23.8, 95% confidence interval 10.7 to 52.5), lymphoedema (71.2, 5.6 to 908), venous insufficiency (2.9, 1.0 to 8.7), leg oedema (2.5, 1.2 to 5.1) and being overweight (2.0, 1.1 to 3.7) were independently associated with erysipelas of the leg. No association was observed with diabetes, alcohol, or smoking. Population attributable risk for toe-web intertrigo was 61%.

Conclusion: This first case-control study highlights the major role of local risk factors (mainly lymphoedema and site of entry) in erysipelas of the leg. From a public health perspective, detecting and treating toe-web intertrigo should be evaluated in the secondary prevention of erysipelas of the leg.

Citing Articles

The prognostic effect and mechanism of erysipelas in cancer-associated lymphedema.

Li P, Zhao Z, Sun Y, Xia S, Shen W Sci Rep. 2025; 15(1):5518.

PMID: 39953144 PMC: 11828868. DOI: 10.1038/s41598-025-90200-2.


Validation of Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and establishment of novel score in Japanese patients with necrotizing fasciitis (J-LRINEC score).

Norimatsu Y, Fukasawa T, Ohno Y, Norimatsu Y, Matsuda K, Hisamoto T J Dermatol. 2025; 52(3):439-444.

PMID: 39916636 PMC: 11883723. DOI: 10.1111/1346-8138.17663.


Global climate change and seasonal variation of cellulitis in hospitalized children: a 30 year retrospective study.

Megged O, Raphael A, Burstyn A, Deri N, Schwartz S, Eisenberg R Epidemiol Infect. 2025; 153:e24.

PMID: 39881621 PMC: 11869086. DOI: 10.1017/S0950268825000032.


Group a remains viable inside fibrin clots and gains access to human plasminogen for subsequent fibrinolysis and dissemination.

Vu H, Moran T, Liang Z, Bao Y, Carles P, Keane J Microbiol Spectr. 2025; 13(2):e0260724.

PMID: 39804237 PMC: 11792473. DOI: 10.1128/spectrum.02607-24.


Combined Use of External Iliac Lymph Node Count and Bone Scintigraphy for PJI Diagnosis: A Prospective Study.

Zhou H, Yang Y, Li J, Hu Q, Li F, Qin L Diagnostics (Basel). 2024; 14(22).

PMID: 39594167 PMC: 11592961. DOI: 10.3390/diagnostics14222502.


References
1.
Kremer M, Zuckerman R, Avraham Z, Raz R . Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect. 1991; 22(1):37-40. DOI: 10.1016/0163-4453(91)90898-3. View

2.
Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc J . Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol. 1989; 125(6):779-82. View

3.
Crickx B, Chevron F, Bilet S, Faucher F, Picard C, Lazareth I . [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)]. Ann Dermatol Venereol. 1991; 118(1):11-6. View

4.
Wacholder S, Silverman D, McLaughlin J, Mandel J . Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol. 1992; 135(9):1029-41. DOI: 10.1093/oxfordjournals.aje.a116397. View

5.
Bernard P . Dermo-hypodermal bacterial infections. Current concepts. Eur J Med. 1992; 1(2):97-104. View